Product Information
METHYLPHENIDATE 5 MG/5 ML SOLN is a generic product labeled by Quagen Pharmaceuticals LLC, priced at $0.0782 per ML under NDC 70752013114. Its NADAC has been published 305 times since Sep 9, 2020.
FDA first approved this application on Jun 4, 2020. Its Orange Book therapeutic-equivalence code is AA.
Strength
5 mg/5mL
Manufacturer
Quagen Pharmaceuticals LLCNDC
70752013114
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213567FDA Approved
6/4/2020
TE Code
AA
On Market Since
6/4/2020
Pharmacological Classes
Price Statistics
The NADAC for METHYLPHENIDATE 5 MG/5 ML SOLN has been published 305 times since Sep 9, 2020, and over the history we have for it it has declined 12.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0782 per ML |
|---|---|
| All-time high | $0.1710 (May 11, 2022) |
| All-time low | $0.0668 (Jul 17, 2024) |
| 52-week high | $0.0827 |
| 52-week low | $0.0744 |
| Median price | $0.0961 |
| Average price | $0.1038 |
| Largest weekly change | +53.1% (Mar 23, 2022) |
| Weeks tracked | 305 |
| Tracking since | Sep 9, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the METHYLPHENIDATE HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Quagen Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
METHYLPHENIDATE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METHYLPHENIDATE 5 MG/5 ML SOLN?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE 5 MG/5 ML SOLN, manufactured by Quagen Pharmaceuticals LLC, is $0.0782 per ML (NDC 70752013114), effective Sep 30, 2026.
How has the price of METHYLPHENIDATE 5 MG/5 ML SOLN changed over time?
Over the history we have for it, the NADAC for METHYLPHENIDATE 5 MG/5 ML SOLN has declined 12.2%. It has been tracked across 305 weekly CMS publications since Sep 9, 2020.
What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE 5 MG/5 ML SOLN?
Since Sep 9, 2020, the NADAC for METHYLPHENIDATE 5 MG/5 ML SOLN has ranged from a low of $0.0668 (Jul 17, 2024) to a high of $0.1710 (May 11, 2022), with a median of $0.0961 per ML.
Are there cheaper alternatives to METHYLPHENIDATE 5 MG/5 ML SOLN?
No other NADAC-published product currently shares the active ingredient and strength of METHYLPHENIDATE 5 MG/5 ML SOLN in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures METHYLPHENIDATE 5 MG/5 ML SOLN?
METHYLPHENIDATE 5 MG/5 ML SOLN (NDC 70752013114) is labeled by Quagen Pharmaceuticals LLC, and CMS classifies it as a generic product.